Früh M - Search Results

1

Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland.

Jürgens V, Ess S, Phuleria HC, Früh M, Schwenkglenks M, Frick H, Cerny T, Vounatsou P. Jürgens V, et al. Among authors: fruh m. Geospat Health. 2013 May;7(2):219-36. doi: 10.4081/gh.2013.82. Geospat Health. 2013. PMID: 23733286 Free article.

2

Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.

Singh N, Daly ME, Ismaila N; Management of Stage III NSCLC Guideline Expert Panel. Singh N, et al. J Clin Oncol. 2023 Sep 20;41(27):4430-4432. doi: 10.1200/JCO.23.01261. Epub 2023 Jul 20. J Clin Oncol. 2023. PMID: 37471673

3

Non-pharmaceutical interventions to optimize cancer immunotherapy.

Boesch M, Baty F, Rassouli F, Kowatsch T, Joerger M, Früh M, Brutsche MH. Boesch M, et al. Among authors: fruh m. Oncoimmunology. 2023 Sep 28;12(1):2255459. doi: 10.1080/2162402X.2023.2255459. eCollection 2023. Oncoimmunology. 2023. PMID: 37791231 Free PMC article. Review.

4

Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR-, HER2-, MET- and ROS1-Alterated Lung Adenocarcinoma.

Plomer E, Früh M, Lauber A, Demmer I, Jochum W, Koster KL. Plomer E, et al. Among authors: fruh m. Int J Mol Sci. 2024 May 23;25(11):5698. doi: 10.3390/ijms25115698. Int J Mol Sci. 2024. PMID: 38891886 Free PMC article.

5

Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.

Daly ME, Singh N, Ismaila N; Management of Stage III NSCLC Guideline Expert Panel. Daly ME, et al. J Clin Oncol. 2024 Sep 1;42(25):3058-3060. doi: 10.1200/JCO-24-01324. Epub 2024 Jul 23. J Clin Oncol. 2024. PMID: 39042842

6

Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports.

Neff D, Padberg Sgier BC, Dietze H, Müller J, Früh M. Neff D, et al. Among authors: fruh m. Case Rep Oncol. 2022 Nov 8;15(3):1001-1008. doi: 10.1159/000526974. eCollection 2022 Sep-Dec. Case Rep Oncol. 2022. PMID: 36636687 Free PMC article.

7

Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.

Schuler A, Huser J, Schmid S, Schär S, Scherz A, Gautschi O, Mauti L, von Briel T, Waibel C, Wannesson L, Pankovics J, Mark MT, Rothschild SI, Addeo A, Janthur WD, Siano M, Boos L, Britschgi C, Früh M. Schuler A, et al. Among authors: fruh m. Lung Cancer. 2024 Jan;187:107427. doi: 10.1016/j.lungcan.2023.107427. Epub 2023 Nov 22. Lung Cancer. 2024. PMID: 38043395

8

Resection of skin metastases from gastric carcinoma with long-term follow-up: an unusual clinical presentation.

Früh M, Ruhstaller T, Neuweiler J, Cerny T. Früh M, et al. Onkologie. 2005 Jan;28(1):38-40. doi: 10.1159/000082266. Onkologie. 2005. PMID: 15604627

9

Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC.

Lanz C, Früh M, Thormann W, Cerny T, Lauterburg BH. Lanz C, et al. Among authors: fruh m. J Sep Sci. 2007 Aug;30(12):1811-20. doi: 10.1002/jssc.200600534. J Sep Sci. 2007. PMID: 17638352

10

Lung cancer in the Canton of St. Gallen, Eastern Switzerland: sex-associated differences in smoking habits, disease presentation and survival.

Cerny D, Cerny T, Ess S, D'Addario G, Früh M. Cerny D, et al. Among authors: fruh m. Onkologie. 2009 Oct;32(10):569-73. doi: 10.1159/000232581. Epub 2009 Sep 14. Onkologie. 2009. PMID: 19816073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters